Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice

• Published in: Human molecular genetics Vol. 18; no. 1; pp. 12 - 26
• Main Authors: Viscomi, Carlo, Spinazzola, Antonella, Maggioni, Marco, Fernandez-Vizarra, Erika, Massa, Valeria, Pagano, Claudio, Vettor, Roberto, Mora, Marina, Zeviani, Massimo
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01-01-2009; Oxford Publishing Limited (England)
• Subjects: Age of Onset; Animals; Biological and medical sciences; Cells, Cultured; Disease Models, Animal; DNA, Mitochondrial - genetics; DNA, Mitochondrial - metabolism; Fibroblasts - metabolism; Fundamental and applied biological sciences. Psychology; Genetics of eukaryotes. Biological and molecular evolution; Glomerulosclerosis, Focal Segmental - epidemiology; Glomerulosclerosis, Focal Segmental - genetics; Glomerulosclerosis, Focal Segmental - metabolism; Humans; Liver - metabolism; Medical sciences; Membrane Proteins - genetics; Membrane Proteins - metabolism; Mice; Mice, Knockout; Mitochondrial Proteins - genetics; Mitochondrial Proteins - metabolism; Molecular and cellular biology; Nephrology. Urinary tract diseases; Organ Specificity; Proteinuria - epidemiology; Proteinuria - genetics; Proteinuria - metabolism; Transcription Factors - genetics; Transcription Factors - metabolism; Transcription, Genetic; Urinary system involvement in other diseases. Miscellaneous; Urinary tract. Prostate gland; Kidney disease; Late; Urinary system disease; Depletion; Nephropathy; Digestive system; Liver; Null mutation; Genetics; Early; Mitochondrial DNA; Proteinuria
• ISSN: 0964-6906; 1460-2083
• DOI: 10.1093/hmg/ddn309

In humans, MPV17 mutations are responsible for severe mitochondrial depletion syndrome, mainly affecting the liver and the nervous system. To gain insight into physiopathology of MPV17-related disease, we investigated an available Mpv17 knockout animal model. We found severe mtDNA depletion in liver and, albeit to a lesser extent, in skeletal muscle, whereas hardly any depletion was detected in brain and kidney, up to 1 year after birth. Mouse embryonic fibroblasts did show mtDNA depletion, but only after several culturing passages, or in a serumless culturing medium. In spite of severe mtDNA depletion, only moderate decrease in respiratory chain enzymatic activities, and mild cytoarchitectural alterations, were observed in the Mpv17−/− livers, but neither cirrhosis nor failure ever occurred in this organ at any age. The mtDNA transcription rate was markedly increased in liver, which could contribute to compensate the severe mtDNA depletion. This phenomenon was associated with specific downregulation of Mterf1, a negative modulator of mtDNA transcription. The most relevant clinical features involved skin, inner ear and kidney. The coat of the Mpv17−/− mice turned gray early in adulthood, and 18-month or older mice developed focal segmental glomerulosclerosis (FSGS) with massive proteinuria. Concomitant degeneration of cochlear sensory epithelia was reported as well. These symptoms were associated with significantly shorter lifespan. Coincidental with the onset of FSGS, there was hardly any mtDNA left in the glomerular tufts. These results demonstrate that Mpv17 controls mtDNA copy number by a highly tissue- and possibly cytotype-specific mechanism.